CN Stock MarketDetailed Quotes

300683 Wuhan Hiteck Biological Pharma

Watchlist
  • 21.99
  • +0.68+3.19%
Market Closed Jun 7 15:00 CST
2.88BMarket Cap-21184P/E (TTM)

Wuhan Hiteck Biological Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-4.87%131.89M
-12.54%602.28M
-19.80%438.43M
-26.03%286.45M
-16.59%138.64M
12.03%688.63M
39.32%546.64M
71.69%387.23M
5.31%166.2M
17.28%614.68M
Operating revenue
-4.87%131.89M
-12.54%602.28M
-19.80%438.43M
-26.03%286.45M
-16.59%138.64M
12.03%688.63M
39.32%546.64M
71.69%387.23M
5.31%166.2M
17.28%614.68M
Other operating revenue
----
-1.04%7.8M
----
197.16%9M
----
21.59%7.89M
----
-17.54%3.03M
----
5.34%6.49M
Total operating cost
20.19%185.59M
3.34%714.28M
-4.78%506.04M
-8.91%329.72M
-4.45%154.42M
14.83%691.22M
42.52%531.42M
66.08%361.96M
11.89%161.62M
14.35%601.93M
Operating cost
1.67%79.25M
-2.77%345.06M
-14.42%244.73M
-19.26%164.68M
-6.43%77.95M
34.02%354.88M
110.45%285.96M
190.40%203.97M
12.40%83.3M
23.69%264.79M
Operating tax surcharges
23.93%1.42M
-2.96%5.47M
-3.49%3.91M
-0.65%2.73M
-4.12%1.15M
58.69%5.64M
43.63%4.05M
17.04%2.75M
18.44%1.19M
13.17%3.55M
Operating expense
-11.48%27.79M
1.55%128.66M
2.63%99.32M
14.04%67.53M
1.64%31.4M
-13.02%126.71M
-6.06%96.78M
-9.27%59.21M
-7.35%30.89M
-4.04%145.66M
Administration expense
114.77%49.44M
20.80%113.33M
7.49%73.08M
8.18%48.42M
15.88%23.02M
-3.58%93.81M
0.95%67.99M
1.94%44.76M
-1.85%19.86M
6.80%97.3M
Financial expense
92.64%-241.53K
36.51%-7.14M
34.95%-5.75M
25.64%-4.77M
3.32%-3.28M
10.32%-11.25M
3.29%-8.83M
2.64%-6.41M
14.10%-3.4M
36.75%-12.54M
-Interest expense (Financial expense)
222.14%1.19M
114.35%2.39M
47.68%1.72M
11.54%1.09M
-28.95%369.05K
124.92%1.12M
259.82%1.16M
506.81%976.19K
--519.4K
7.14%496.72K
-Interest Income (Financial expense)
57.45%-1.62M
22.29%-9.99M
24.79%-7.79M
18.35%-6.11M
5.69%-3.8M
5.45%-12.86M
-5.76%-10.36M
-6.48%-7.48M
---4.03M
34.79%-13.6M
Research and development
15.47%27.94M
6.15%128.9M
6.16%90.74M
-11.37%51.13M
-18.70%24.2M
17.71%121.43M
17.20%85.47M
34.87%57.69M
51.11%29.76M
19.79%103.17M
Credit Impairment Loss
-40.39%564.6K
74.31%-974.97K
9,122.68%2.16M
253.44%2.09M
122.90%947.22K
-115.97%-3.79M
100.17%23.43K
88.08%-1.36M
41.81%-4.14M
93.99%-1.76M
Asset Impairment Loss
370.69%17.7M
-81.03%-60.12M
118.76%1.69M
148.90%3.11M
--3.76M
-183.99%-33.21M
-17.79%-8.99M
-28.90%-6.36M
----
46.85%-11.69M
Other net revenue
179.60%25.81M
-635.32%-31.08M
276.72%24.53M
1,327.85%20.48M
651.66%9.23M
-149.24%-4.23M
196.46%6.51M
123.24%1.43M
-73.86%1.23M
126.18%8.58M
Fair value change income
149.25%5.81M
-85.02%1.9M
241.85%11.65M
1,143.19%6.81M
-10.20%2.33M
3,903.39%12.67M
335.88%3.41M
38.08%-653.22K
194.94%2.59M
95.13%-333.23K
Invest income
10,050.76%239.11K
42.06%15.69M
-44.36%2.99M
-63.66%2.15M
-98.48%2.36K
-23.00%11.04M
-47.12%5.37M
-29.83%5.91M
-98.24%155.14K
-26.39%14.34M
-Including: Investment income associates
----
-15.16%-2.77M
----
----
----
-9,453.53%-2.4M
----
----
----
---25.16K
Asset deal income
-210.95%-43.5K
-282.04%-358.67K
-828.31%-2.18M
143.06%39.21K
--39.21K
48.12%-93.88K
684.93%299.27K
-85.71%-91.05K
----
-109.61%-180.96K
Other revenue
-28.26%1.54M
39.69%12.79M
28.58%8.23M
57.06%6.28M
-17.65%2.15M
11.53%9.16M
8.67%6.4M
38.16%4M
20.31%2.61M
39.09%8.21M
Operating profit
-325.78%-27.89M
-1,997.07%-143.07M
-298.19%-43.07M
-185.32%-22.78M
-212.60%-6.55M
-131.97%-6.82M
70.47%21.73M
1,762.08%26.71M
-67.84%5.82M
160.84%21.34M
Add:Non operating Income
-96.16%3.75K
-59.40%172.06K
-43.20%121.85K
-32.71%112.15K
-96.69%97.53K
-28.81%423.83K
-62.53%214.51K
-19.48%166.67K
9,895.44%2.95M
139.43%595.37K
Less:Non operating expense
54.39%559.25K
537.43%9.09M
697.99%6.22M
265.72%2.05M
59.65%362.23K
-3.65%1.43M
-16.04%779.56K
-17.20%559.31K
37.46%226.89K
-41.79%1.48M
Total profit
-317.39%-28.45M
-1,842.57%-151.99M
-332.29%-49.17M
-193.94%-24.72M
-179.82%-6.82M
-138.25%-7.82M
70.81%21.17M
2,624.82%26.31M
-52.45%8.54M
154.74%20.46M
Less:Income tax cost
-114.80%-10.95M
-32,106.33%-23.74M
-453.74%-19.56M
-1,228.50%-11.9M
-228.44%-5.1M
100.78%74.18K
47.02%-3.53M
121.39%1.05M
-140.99%-1.55M
18.26%-9.56M
Net profit
FPtoL-17.49M
FPtoL-128.24M
SL-29.62M
SL-12.82M
SL-1.72M
SL-7.9M
29.60%24.7M
328.48%25.26M
-28.77%10.09M
FLtoP30.01M
Net profit from continuing operation
-919.75%-17.49M
-1,523.72%-128.24M
-219.90%-29.62M
-150.74%-12.82M
-117.00%-1.72M
-126.31%-7.9M
29.60%24.7M
328.48%25.26M
-28.77%10.09M
216.91%30.01M
Less:Minority Profit
-288.92%-946.15K
-221.02%-7.42M
-154.04%-3.18M
-126.45%-1.69M
-110.14%-243.28K
159.73%6.13M
1,289.40%5.88M
583.12%6.39M
761.82%2.4M
463.99%2.36M
Net profit of parent company owners
-1,024.00%-16.55M
-761.20%-120.82M
-240.47%-26.44M
-158.96%-11.13M
-119.14%-1.47M
-150.73%-14.03M
1.00%18.82M
161.49%18.87M
-47.07%7.69M
210.50%27.65M
Earning per share
Basic earning per share
-550.00%-0.13
-745.45%-0.93
-240.00%-0.21
-160.00%-0.09
-133.33%-0.02
-142.31%-0.11
-16.67%0.15
114.29%0.15
-57.14%0.06
208.33%0.26
Diluted earning per share
-550.00%-0.13
-745.45%-0.93
-240.00%-0.21
-160.00%-0.09
-133.33%-0.02
-142.31%-0.11
-16.67%0.15
114.29%0.15
-57.14%0.06
208.33%0.26
Other composite income
Total composite income
-919.75%-17.49M
-1,523.72%-128.24M
-219.90%-29.62M
-150.74%-12.82M
-117.00%-1.72M
-126.31%-7.9M
29.60%24.7M
328.48%25.26M
-28.77%10.09M
216.91%30.01M
Total composite income of parent company owners
-1,024.00%-16.55M
-761.20%-120.82M
-240.47%-26.44M
-158.96%-11.13M
-119.14%-1.47M
-150.73%-14.03M
1.00%18.82M
161.49%18.87M
-47.07%7.69M
210.50%27.65M
Total composite income of minority owners
-288.92%-946.15K
-221.02%-7.42M
-154.04%-3.18M
-126.45%-1.69M
-110.14%-243.28K
159.73%6.13M
1,289.40%5.88M
583.12%6.39M
761.82%2.4M
463.99%2.36M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -4.87%131.89M-12.54%602.28M-19.80%438.43M-26.03%286.45M-16.59%138.64M12.03%688.63M39.32%546.64M71.69%387.23M5.31%166.2M17.28%614.68M
Operating revenue -4.87%131.89M-12.54%602.28M-19.80%438.43M-26.03%286.45M-16.59%138.64M12.03%688.63M39.32%546.64M71.69%387.23M5.31%166.2M17.28%614.68M
Other operating revenue -----1.04%7.8M----197.16%9M----21.59%7.89M-----17.54%3.03M----5.34%6.49M
Total operating cost 20.19%185.59M3.34%714.28M-4.78%506.04M-8.91%329.72M-4.45%154.42M14.83%691.22M42.52%531.42M66.08%361.96M11.89%161.62M14.35%601.93M
Operating cost 1.67%79.25M-2.77%345.06M-14.42%244.73M-19.26%164.68M-6.43%77.95M34.02%354.88M110.45%285.96M190.40%203.97M12.40%83.3M23.69%264.79M
Operating tax surcharges 23.93%1.42M-2.96%5.47M-3.49%3.91M-0.65%2.73M-4.12%1.15M58.69%5.64M43.63%4.05M17.04%2.75M18.44%1.19M13.17%3.55M
Operating expense -11.48%27.79M1.55%128.66M2.63%99.32M14.04%67.53M1.64%31.4M-13.02%126.71M-6.06%96.78M-9.27%59.21M-7.35%30.89M-4.04%145.66M
Administration expense 114.77%49.44M20.80%113.33M7.49%73.08M8.18%48.42M15.88%23.02M-3.58%93.81M0.95%67.99M1.94%44.76M-1.85%19.86M6.80%97.3M
Financial expense 92.64%-241.53K36.51%-7.14M34.95%-5.75M25.64%-4.77M3.32%-3.28M10.32%-11.25M3.29%-8.83M2.64%-6.41M14.10%-3.4M36.75%-12.54M
-Interest expense (Financial expense) 222.14%1.19M114.35%2.39M47.68%1.72M11.54%1.09M-28.95%369.05K124.92%1.12M259.82%1.16M506.81%976.19K--519.4K7.14%496.72K
-Interest Income (Financial expense) 57.45%-1.62M22.29%-9.99M24.79%-7.79M18.35%-6.11M5.69%-3.8M5.45%-12.86M-5.76%-10.36M-6.48%-7.48M---4.03M34.79%-13.6M
Research and development 15.47%27.94M6.15%128.9M6.16%90.74M-11.37%51.13M-18.70%24.2M17.71%121.43M17.20%85.47M34.87%57.69M51.11%29.76M19.79%103.17M
Credit Impairment Loss -40.39%564.6K74.31%-974.97K9,122.68%2.16M253.44%2.09M122.90%947.22K-115.97%-3.79M100.17%23.43K88.08%-1.36M41.81%-4.14M93.99%-1.76M
Asset Impairment Loss 370.69%17.7M-81.03%-60.12M118.76%1.69M148.90%3.11M--3.76M-183.99%-33.21M-17.79%-8.99M-28.90%-6.36M----46.85%-11.69M
Other net revenue 179.60%25.81M-635.32%-31.08M276.72%24.53M1,327.85%20.48M651.66%9.23M-149.24%-4.23M196.46%6.51M123.24%1.43M-73.86%1.23M126.18%8.58M
Fair value change income 149.25%5.81M-85.02%1.9M241.85%11.65M1,143.19%6.81M-10.20%2.33M3,903.39%12.67M335.88%3.41M38.08%-653.22K194.94%2.59M95.13%-333.23K
Invest income 10,050.76%239.11K42.06%15.69M-44.36%2.99M-63.66%2.15M-98.48%2.36K-23.00%11.04M-47.12%5.37M-29.83%5.91M-98.24%155.14K-26.39%14.34M
-Including: Investment income associates -----15.16%-2.77M-------------9,453.53%-2.4M---------------25.16K
Asset deal income -210.95%-43.5K-282.04%-358.67K-828.31%-2.18M143.06%39.21K--39.21K48.12%-93.88K684.93%299.27K-85.71%-91.05K-----109.61%-180.96K
Other revenue -28.26%1.54M39.69%12.79M28.58%8.23M57.06%6.28M-17.65%2.15M11.53%9.16M8.67%6.4M38.16%4M20.31%2.61M39.09%8.21M
Operating profit -325.78%-27.89M-1,997.07%-143.07M-298.19%-43.07M-185.32%-22.78M-212.60%-6.55M-131.97%-6.82M70.47%21.73M1,762.08%26.71M-67.84%5.82M160.84%21.34M
Add:Non operating Income -96.16%3.75K-59.40%172.06K-43.20%121.85K-32.71%112.15K-96.69%97.53K-28.81%423.83K-62.53%214.51K-19.48%166.67K9,895.44%2.95M139.43%595.37K
Less:Non operating expense 54.39%559.25K537.43%9.09M697.99%6.22M265.72%2.05M59.65%362.23K-3.65%1.43M-16.04%779.56K-17.20%559.31K37.46%226.89K-41.79%1.48M
Total profit -317.39%-28.45M-1,842.57%-151.99M-332.29%-49.17M-193.94%-24.72M-179.82%-6.82M-138.25%-7.82M70.81%21.17M2,624.82%26.31M-52.45%8.54M154.74%20.46M
Less:Income tax cost -114.80%-10.95M-32,106.33%-23.74M-453.74%-19.56M-1,228.50%-11.9M-228.44%-5.1M100.78%74.18K47.02%-3.53M121.39%1.05M-140.99%-1.55M18.26%-9.56M
Net profit FPtoL-17.49MFPtoL-128.24MSL-29.62MSL-12.82MSL-1.72MSL-7.9M29.60%24.7M328.48%25.26M-28.77%10.09MFLtoP30.01M
Net profit from continuing operation -919.75%-17.49M-1,523.72%-128.24M-219.90%-29.62M-150.74%-12.82M-117.00%-1.72M-126.31%-7.9M29.60%24.7M328.48%25.26M-28.77%10.09M216.91%30.01M
Less:Minority Profit -288.92%-946.15K-221.02%-7.42M-154.04%-3.18M-126.45%-1.69M-110.14%-243.28K159.73%6.13M1,289.40%5.88M583.12%6.39M761.82%2.4M463.99%2.36M
Net profit of parent company owners -1,024.00%-16.55M-761.20%-120.82M-240.47%-26.44M-158.96%-11.13M-119.14%-1.47M-150.73%-14.03M1.00%18.82M161.49%18.87M-47.07%7.69M210.50%27.65M
Earning per share
Basic earning per share -550.00%-0.13-745.45%-0.93-240.00%-0.21-160.00%-0.09-133.33%-0.02-142.31%-0.11-16.67%0.15114.29%0.15-57.14%0.06208.33%0.26
Diluted earning per share -550.00%-0.13-745.45%-0.93-240.00%-0.21-160.00%-0.09-133.33%-0.02-142.31%-0.11-16.67%0.15114.29%0.15-57.14%0.06208.33%0.26
Other composite income
Total composite income -919.75%-17.49M-1,523.72%-128.24M-219.90%-29.62M-150.74%-12.82M-117.00%-1.72M-126.31%-7.9M29.60%24.7M328.48%25.26M-28.77%10.09M216.91%30.01M
Total composite income of parent company owners -1,024.00%-16.55M-761.20%-120.82M-240.47%-26.44M-158.96%-11.13M-119.14%-1.47M-150.73%-14.03M1.00%18.82M161.49%18.87M-47.07%7.69M210.50%27.65M
Total composite income of minority owners -288.92%-946.15K-221.02%-7.42M-154.04%-3.18M-126.45%-1.69M-110.14%-243.28K159.73%6.13M1,289.40%5.88M583.12%6.39M761.82%2.4M463.99%2.36M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg